{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:33:56Z","timestamp":1789450436808,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.yebeh.2020.107732","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T03:32:53Z","timestamp":1611372773000},"page":"107732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations"],"prefix":"10.1016","volume":"116","author":[{"given":"Mary E.","family":"Moya-Mendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1180-0287","authenticated-orcid":false,"given":"David M.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen","family":"Hunanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Kucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Prange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Jasien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Keough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Shashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad A.","family":"Mikati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yebeh.2020.107732_b0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ana.10674","article-title":"Novel mutations in the Na+, K+-ATPase pump geneATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions","volume":"54","author":"Vanmolkot","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2020.107732_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59566\/IJBS.2014.10085","article-title":"Brain Na(+), K(+)-ATPase activity in aging and disease","volume":"10","author":"de Lores Arnaiz","year":"2014","journal-title":"Int J Biomed Sci"},{"key":"10.1016\/j.yebeh.2020.107732_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0098469","article-title":"Role of Na, K-ATPase \u03b11 and \u03b12 isoforms in the support of astrocyte glutamate uptake","volume":"9","author":"Illarionava","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107732_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/1479-7364-7-8","article-title":"Genetic effects of ATP1A2 in familial hemiplegic migraine type II and animal models","volume":"7","author":"Gritz","year":"2013","journal-title":"Hum Genomics"},{"issue":"5","key":"10.1016\/j.yebeh.2020.107732_b0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.ejhg.5201607","article-title":"Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine","volume":"14","author":"Vanmolkot","year":"2006","journal-title":"Eur J Hum Genet"},{"issue":"1-2","key":"10.1016\/j.yebeh.2020.107732_b0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2008.06.006","article-title":"A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures","volume":"273","author":"Gallanti","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2020.107732_b0035","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1528-1167.2007.01415.x","article-title":"Epilepsy as part of the phenotype associated with ATP1A2 mutations","volume":"49","author":"Deprez","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107732_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009750","article-title":"Acute encephalopathy in familial hemiplegic migraine with ATP1A2 mutation","volume":"2013","author":"Merwick","year":"2013","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.yebeh.2020.107732_b0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1440-1754.2009.01465.x","article-title":"Profound encephalopathy with complete recovery in three children with familial hemiplegic migraine","volume":"45","author":"Hart","year":"2009","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.yebeh.2020.107732_b0050","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1097\/WNP.0000000000000387","article-title":"Familial hemiplegic migraine with asymmetric encephalopathy secondary to ATP1A2 mutation: a case series","volume":"35","author":"Murphy","year":"2018","journal-title":"J Clin Neurophysiol"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107732_b0055","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1526-4610.2005.00249.x","article-title":"Familial hemiplegic migraine presenting as recurrent encephalopathy in a native indian family","volume":"45","author":"Spacey","year":"2005","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107732_b0060","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.braindev.2011.11.002","article-title":"Sporadic hemiplegic migraine presenting as acute encephalopathy","volume":"34","author":"Ohmura","year":"2012","journal-title":"Brain and Development"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107732_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/jmt.2009.17.3.163","article-title":"Global rating of change scales: a review of strengths and weaknesses and considerations for design","volume":"17","author":"Kamper","year":"2009","journal-title":"J Manual Manipulative Therapy"},{"key":"10.1016\/j.yebeh.2020.107732_b0070","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.yebeh.2020.107732_b0075","unstructured":"The PyMOL Molecular Graphics System. In: Delano Scientific, San Carlos; 2002."},{"issue":"1","key":"10.1016\/j.yebeh.2020.107732_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/srep42661","article-title":"Optimization of the production of knock-in alleles by CRISPR\/Cas9 microinjection into the mouse zygote","volume":"7","author":"Raveux","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107732_b0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/epi.12878","article-title":"Knock-in mouse model of alternating hemiplegia of childhood: Behavioral and electrophysiologic characterization","volume":"56","author":"Hunanyan","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107732_b0090","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2018.07.028","article-title":"Novel E815K knock-in mouse model of alternating hemiplegia of childhood","volume":"119","author":"Helseth","year":"2018","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.yebeh.2020.107732_b0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/epi.14480","article-title":"Intravenous ketamine in status epilepticus","volume":"59","author":"H\u00f6fler","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107732_b0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1059-1311(03)00028-1","article-title":"Oral ketamine in paediatric non-convulsive status epilepticus","volume":"12","author":"Mewasingh","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107732_b0105","first-page":"166","article-title":"Memantine: a review of possible uses in child and adolescent psychiatry","volume":"22","author":"Hosenbocus","year":"2013","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"9","key":"10.1016\/j.yebeh.2020.107732_b0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","article-title":"Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy","volume":"55","author":"Peltoniemi","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107732_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/srep22047","article-title":"Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model","volume":"6","author":"B\u00f8ttger","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2020.107732_b0120","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1523\/JNEUROSCI.23-11-04667.2003","article-title":"Degeneration of the amygdala\/piriform cortex and enhanced fear\/anxiety behaviors in sodium pump \u03b12 subunit ATP1A2-deficient mice","volume":"23","author":"Ikeda","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.yebeh.2020.107732_b0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fphys.2016.00195","article-title":"The influence of Na(+), K(+)-ATPase on glutamate signaling in neurodegenerative diseases and senescence","volume":"7","author":"Kinoshita","year":"2016","journal-title":"Front Physiol"},{"issue":"7470","key":"10.1016\/j.yebeh.2020.107732_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12578","article-title":"Crystal structure of a Na+-bound Na+,K+-ATPase preceding the E1P state","volume":"502","author":"Kanai","year":"2013","journal-title":"Nature"},{"issue":"7311","key":"10.1016\/j.yebeh.2020.107732_b0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature09309","article-title":"Neurological disease mutations compromise a C-terminal ion pathway in the Na+\/K+-ATPase","volume":"467","author":"Poulsen","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2020.107732_b0140","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1093\/nar\/gkl556","article-title":"Comprehensive splice-site analysis using comparative genomics","volume":"34","author":"Sheth","year":"2006","journal-title":"Nucl. Acids Res."},{"issue":"8","key":"10.1016\/j.yebeh.2020.107732_b0145","doi-asserted-by":"crossref","first-page":"a033928","DOI":"10.1101\/cshperspect.a033928","article-title":"Chaperoning Endoplasmic Reticulum\u2013Associated Degradation (ERAD) and protein conformational diseases","volume":"11","author":"Needham","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.yebeh.2020.107732_b0150","doi-asserted-by":"crossref","unstructured":"Sinner B, Graf BM. Ketamine. In: Sch\u00fcttler J, Schwilden H, editors. Modern Anesthetics. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008, p. 313-333.","DOI":"10.1007\/978-3-540-74806-9_15"},{"key":"10.1016\/j.yebeh.2020.107732_b0155","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1542\/peds.2017-0852","article-title":"Clinical benefit of NMDA receptor antagonists in a patient with ATP1A2 gene mutation","volume":"141","author":"Ueda","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2020.107732_b0160","first-page":"87","article-title":"Early treatment in acute severe encephalopathy caused by ATP1A2 mutation of familial hemiplegic migraine type 2: case report and literature review","author":"Ying Du","year":"2020","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2020.107732_b0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yebeh.2019.04.042","article-title":"Novel therapies for epilepsy in the pipeline","volume":"97","author":"Mesraoua","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107732_b0170","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/epi.14441","article-title":"Mechanisms of increased hippocampal excitability in the Mashl+\/\u2212 mouse model of Na+\/K+-ATPase dysfunction","volume":"59","author":"Hunanyan","year":"2018","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020309124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020309124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:35:17Z","timestamp":1761503717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020309124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":34,"alternative-id":["S1525505020309124"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107732","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107732"}}